http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140021155-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17c6c7da627b7bead7208250127b52c2 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2513-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0645 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-19 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
| filingDate | 2012-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_beb731b96fa59dcde5ab2c5d3001ad31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6271dbf7b08ccc3d370492706171a51d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0d0594c61c4ec95d101b5c953e82d85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9675f7a2591f6d0b4e800dc9e7ca415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce4f2b71f3815835c2e695f1e33c3b3b |
| publicationDate | 2014-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20140021155-A |
| titleOfInvention | Pharmaceutical composition for promoting lymphatic vessel formation including human blood-derived blood cell mass |
| abstract | The present invention relates to a method for promoting lymph-vessel formation by effectively cultivating and proliferating lymphocyte adult stem cells and progenitor cells which are present only in a trace amount in blood using blood mononuclear cells and their use, A pharmaceutical composition for promoting the formation of lymph vessels, and the like. Accordingly, the present invention provides a method for culturing a large amount of cultured lymphocyte stem cells and progenitor cells through in vitro culturing of autologous blood mononuclear cells, and ultimately, a method for treating a disease having a lymphangiogenesis abnormality and a disorder . According to the present invention, it is expected that a large amount of hematopoietic stem cells and progenitor cells can be obtained, and it can contribute to the development of an optimal autologous cell-derived cell therapy agent for the purpose of cell therapy for lymph-related diseases. |
| priorityDate | 2012-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 250.